All Articles

In a landmark move, Baker Tilly is partnering with the powerhouse AI firm Ode to supercharge its human experts. Is this the new blueprint for professional services?

VPNs promise privacy but often sacrifice speed. Surfshark's FastTrack technology challenges this, using smart routing to find faster paths on the internet.

After a two-year engagement, Galaxy Gaming's merger with Evolution is stalled by regulatory hurdles. Frank Reed analyzes a deal teetering on the brink.

A firm's acquisition of a San Leandro apartment complex highlights a growing trend: using private capital to preserve affordability in America's toughest markets.

Dissecting 3 E Network’s custom AI chip for eldercare robots, a strategic maneuver that signals a new front in the AI hardware wars: hyper-specialization.

IntelliGenome's revolutionary CRISPR-TB diagnostic arrives in South Africa via a key partnership, offering a new, blood-based tool to tackle the TB crisis.

BIOTRONIK Neuro's new AI doesn't just track pain; it anticipates needs, shifting spinal cord stimulation from reactive treatment to proactive, personalized care.

Marpai's $26.4M debt restructuring isn't just about survival. It's a strategic pivot to fuel its AI platform and challenge healthcare administration giants.

A 40-year-old audio giant is challenging high-end norms with a compact speaker platform, betting that integrated design is the future of the industry.

Edge intelligence firm RMX Industries adds former Texas Secretary of State John Scott to its board, a move that telegraphs a serious play for government contracts.

Ottawa extends Babcock Canada’s submarine support contract by six years, a $1.1B deal vital for the current fleet and the transition to a new generation.

With a massive IPO and backing from Agnico Eagle, Cadillac Mines is not just raising capital; it's signaling a major shift in Canada's mining landscape.

VIO's new design isn't just about aesthetics. It's a calculated move to lower franchisee costs, enhance the guest experience, and scale a premium brand.

SuanNutra's acquisition of IFF's specialty businesses isn't just a deal; it's a strategic consolidation in the booming clean-label market. Here's why.

A key executive move at DLC reveals a deeper strategy: the transformation of open-air shopping centers into the essential physical backbone of our digital lives.

With promising new data, Nuvation Bio is launching a bold, multi-front clinical strategy for its brain cancer drug. Is this the move that will outmaneuver competitors?

New data reveals a dangerous paradox in Canada's foodservice sector. While sales are growing, soaring costs are erasing profits, stifling investment.

Kamada's new plasma supply agreement is more than just revenue; it's a bold validation of its vertical integration strategy in a competitive global market.

The national 'Click-to-Cancel' rule is dead, but a new regulatory web of state laws and payment processor rules creates a minefield for global startups.